Isoclean® Pharmacy Compounding Aseptic Isolator by Esco Technologies Inc
Manufacturer Esco Technologies Inc
Esco Isoclean Pharmacy Compounding Aseptic Isolator, provides a safe and clean environment for compounding of non-hazardous, sterile drug preparations and IV admixtures in compliance with USP 797* criteria. Barrier isolation system provides inherently superior sterility compared to open fronted clean air devices such as laminar flow clean benches and Class II biological safety cabinets. USP797 guidelines specify that isolators may be situated in an area subject to less severe environmental contr... Read more
Isoclean® Pharmacy Compounding Aseptic Isolator
Esco Isoclean Pharmacy Compounding Aseptic Isolator, provides a safe and clean environment for compounding of non-hazardous, sterile drug preparations and IV admixtures in compliance with USP 797* criteria.
Barrier isolation system provides inherently superior sterility compared to open fronted clean air devices such as laminar flow clean benches and Class II biological safety cabinets. USP797 guidelines specify that isolators may be situated in an area subject to less severe environmental controls compared with open fronted clean air devices.
When used as part of a system that includes operator aseptic technique training, process validation, expiration setting, and product quality maintenance after the CSP leaves the pharmacy, isolators are a cost-effective solution especially for lower-volume pharmacies. They reduce operating and renovation costs, take up less space, and are easier to maintain.
The Isoclean Pharmacy Compounding Aseptic Isolator is suitable for work involving non-hazardous materials. The work zone and pass-thru interchange are under positive pressure to the room in order to maintain sterility in case of a breach in the barrier isolation system. Negative pressure models should be selected for antineoplastic or cytotoxic compounding applications.
*United States Pharmacopoeia (USP), Chapter 797(1), enacted January 1, 2004, presents the first enforceable standards for sterile compounding. Following years of patient safety recommendations and professional guidelines, the intent of USP 797 is to set forth the procedural and practical requirements for safe compounding of sterile preparations. The Chapter's requirements are applicable in all practice settings where sterile preparations are compounded.
Barrier isolation system provides inherently superior sterility compared to open fronted clean air devices such as laminar flow clean benches and Class II biological safety cabinets. USP797 guidelines specify that isolators may be situated in an area subject to less severe environmental controls compared with open fronted clean air devices.
When used as part of a system that includes operator aseptic technique training, process validation, expiration setting, and product quality maintenance after the CSP leaves the pharmacy, isolators are a cost-effective solution especially for lower-volume pharmacies. They reduce operating and renovation costs, take up less space, and are easier to maintain.
The Isoclean Pharmacy Compounding Aseptic Isolator is suitable for work involving non-hazardous materials. The work zone and pass-thru interchange are under positive pressure to the room in order to maintain sterility in case of a breach in the barrier isolation system. Negative pressure models should be selected for antineoplastic or cytotoxic compounding applications.
*United States Pharmacopoeia (USP), Chapter 797(1), enacted January 1, 2004, presents the first enforceable standards for sterile compounding. Following years of patient safety recommendations and professional guidelines, the intent of USP 797 is to set forth the procedural and practical requirements for safe compounding of sterile preparations. The Chapter's requirements are applicable in all practice settings where sterile preparations are compounded.
Product Overview
Isoclean® Pharmacy Compounding Aseptic Isolator
Manufacturer Esco Technologies Inc
Be the first to review this product